NASDAQ:XLO | Insider Transactions | Xilio Therapeutics, Inc.

XLO Insider Transactions

92 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–92; provenance stays internal.

XLO insiders transaction timeline

PurchaseSale
2021-10-26: 22 purchases — SV7 Impact Medicine Fund LP, SV7 (IMF) GP LLP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) and 12 more2021-12-08: 6 purchases — BCIP Life Sciences Associates, LP, Bain Capital Life Sciences Investors, LLC, Bain Capital Life Sciences Fund II, L.P. and 3 more2021-12-09: 6 purchases — BCIP Life Sciences Associates, LP, Bain Capital Life Sciences Investors, LLC, Bain Capital Life Sciences Fund II, L.P. and 3 more2021-12-10: 12 purchases — BCIP Life Sciences Associates, LP, Bain Capital Life Sciences Investors, LLC, Bain Capital Life Sciences Fund II, L.P. and 3 more2024-01-11: 12 sales — Atlas Venture Fund XI, L.P., Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P. and 3 more2024-01-12: 12 sales — Atlas Venture Fund XI, L.P., Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P. and 3 more2024-02-08: 12 sales — Atlas Venture Fund XI, L.P., Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P. and 3 more2024-04-02: 1 purchase — GILEAD SCIENCES, INC.2024-12-18: 1 purchase — GILEAD SCIENCES, INC.2025-01-02: 2 sales — Frankenfield Christopher James, Brennan Kevin M.2025-06-16: 2 purchases — Shannon James Samuel, Russo Rene2025-06-17: 1 purchase — Shannon James Samuel2026-01-02: 2 sales — Brennan Kevin M., Frankenfield Christopher James2026-03-26: 1 purchase — Shannon James Samuel2021-10-262026-03-26
Insider profileRoleDateTransactionSharesPrice
Shannon James SamuelDirector2026-03-26Purchase5,000.0$8.79
Brennan Kevin M.SVP, FINANCE AND ACCOUNTING2026-01-02Sale1,826.0$0.64
Frankenfield Christopher JamesChief Financial Officer2026-01-02Sale7,030.0$0.64
Shannon James SamuelDirector2025-06-17Purchase25,000.0$0.69
Shannon James SamuelDirector2025-06-16Purchase45,000.0$0.69
Russo RenePRESIDENT AND CEO2025-06-16Purchase36,289.0$0.68
Frankenfield Christopher JamesChief Financial Officer2025-01-02Sale6,954.0$0.98
Brennan Kevin M.SVP, FINANCE AND ACCOUNTING2025-01-02Sale1,803.0$0.98
GILEAD SCIENCES, INC.TenPercentOwner2024-12-18Purchase1,759,978.0$1.04
GILEAD SCIENCES, INC.TenPercentOwner2024-04-02Purchase485,250.0$0.76
Atlas Venture Fund XI, L.P.TenPercentOwner2024-02-08Sale267.0$0.64
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2024-02-08Sale267.0$0.64
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2024-02-08Sale267.0$0.64
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2024-02-08Sale267.0$0.64
Atlas Venture Associates XI, LLCTenPercentOwner2024-02-08Sale267.0$0.64
Atlas Venture Associates XI, L.P.TenPercentOwner2024-02-08Sale267.0$0.64
Atlas Venture Fund XI, L.P.TenPercentOwner2024-02-08Sale733.0$0.64
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2024-02-08Sale733.0$0.64
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2024-02-08Sale733.0$0.64
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2024-02-08Sale733.0$0.64
Atlas Venture Associates XI, LLCTenPercentOwner2024-02-08Sale733.0$0.64
Atlas Venture Associates XI, L.P.TenPercentOwner2024-02-08Sale733.0$0.64
Atlas Venture Fund XI, L.P.TenPercentOwner2024-01-12Sale560.0$0.83
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2024-01-12Sale560.0$0.83
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2024-01-12Sale560.0$0.83
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2024-01-12Sale560.0$0.83
Atlas Venture Associates XI, LLCTenPercentOwner2024-01-12Sale560.0$0.83
Atlas Venture Associates XI, L.P.TenPercentOwner2024-01-12Sale560.0$0.83
Atlas Venture Fund XI, L.P.TenPercentOwner2024-01-12Sale1,540.0$0.83
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2024-01-12Sale1,540.0$0.83
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2024-01-12Sale1,540.0$0.83
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2024-01-12Sale1,540.0$0.83
Atlas Venture Associates XI, LLCTenPercentOwner2024-01-12Sale1,540.0$0.83
Atlas Venture Associates XI, L.P.TenPercentOwner2024-01-12Sale1,540.0$0.83
Atlas Venture Fund XI, L.P.TenPercentOwner2024-01-11Sale569.0$0.87
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2024-01-11Sale569.0$0.87
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2024-01-11Sale569.0$0.87
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2024-01-11Sale569.0$0.87
Atlas Venture Associates XI, LLCTenPercentOwner2024-01-11Sale569.0$0.87
Atlas Venture Associates XI, L.P.TenPercentOwner2024-01-11Sale569.0$0.87
Atlas Venture Fund XI, L.P.TenPercentOwner2024-01-11Sale1,566.0$0.87
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2024-01-11Sale1,566.0$0.87
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2024-01-11Sale1,566.0$0.87
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2024-01-11Sale1,566.0$0.87
Atlas Venture Associates XI, LLCTenPercentOwner2024-01-11Sale1,566.0$0.87
Atlas Venture Associates XI, L.P.TenPercentOwner2024-01-11Sale1,566.0$0.87
BCIP Life Sciences Associates, LPTenPercentOwner2021-12-10Purchase3,188.0$10.24
Bain Capital Life Sciences Investors, LLCTenPercentOwner2021-12-10Purchase3,188.0$10.24
Bain Capital Life Sciences Fund II, L.P.TenPercentOwner2021-12-10Purchase3,188.0$10.24
Bain Capital Life Sciences Investors II, LLCTenPercentOwner2021-12-10Purchase3,188.0$10.24
BCLS II Investco, LPTenPercentOwner2021-12-10Purchase3,188.0$10.24
BCLS II Investo (GP), LLCTenPercentOwner2021-12-10Purchase3,188.0$10.24
BCIP Life Sciences Associates, LPTenPercentOwner2021-12-10Purchase21,812.0$9.56
Bain Capital Life Sciences Investors, LLCTenPercentOwner2021-12-10Purchase21,812.0$9.56
Bain Capital Life Sciences Fund II, L.P.TenPercentOwner2021-12-10Purchase21,812.0$9.56
Bain Capital Life Sciences Investors II, LLCTenPercentOwner2021-12-10Purchase21,812.0$9.56
BCLS II Investco, LPTenPercentOwner2021-12-10Purchase21,812.0$9.56
BCLS II Investo (GP), LLCTenPercentOwner2021-12-10Purchase21,812.0$9.56
BCIP Life Sciences Associates, LPTenPercentOwner2021-12-09Purchase4,011.0$9.84
Bain Capital Life Sciences Investors, LLCTenPercentOwner2021-12-09Purchase4,011.0$9.84
Bain Capital Life Sciences Fund II, L.P.TenPercentOwner2021-12-09Purchase4,011.0$9.84
Bain Capital Life Sciences Investors II, LLCTenPercentOwner2021-12-09Purchase4,011.0$9.84
BCLS II Investco, LPTenPercentOwner2021-12-09Purchase4,011.0$9.84
BCLS II Investo (GP), LLCTenPercentOwner2021-12-09Purchase4,011.0$9.84
BCIP Life Sciences Associates, LPTenPercentOwner2021-12-08Purchase13,458.0$9.62
Bain Capital Life Sciences Investors, LLCTenPercentOwner2021-12-08Purchase13,458.0$9.62
Bain Capital Life Sciences Fund II, L.P.TenPercentOwner2021-12-08Purchase13,458.0$9.62
Bain Capital Life Sciences Investors II, LLCTenPercentOwner2021-12-08Purchase13,458.0$9.62
BCLS II Investco, LPTenPercentOwner2021-12-08Purchase13,458.0$9.62
BCLS II Investo (GP), LLCTenPercentOwner2021-12-08Purchase13,458.0$9.62
SV7 Impact Medicine Fund LPTenPercentOwner2021-10-26Purchase312,500.0$16.0
SV7 (IMF) GP LLPTenPercentOwner2021-10-26Purchase312,500.0$16.0
SV7 Impact Medicine Fund LPTenPercentOwner2021-10-26Purchase312,500.0$16.0
SV7 (IMF) GP LLPTenPercentOwner2021-10-26Purchase312,500.0$16.0
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)TenPercentOwnerOther2021-10-26Purchase387,500.0$16.0
Deerfield Mgmt L.P.TenPercentOwnerOther2021-10-26Purchase387,500.0$16.0
DEERFIELD PARTNERS, L.P.TenPercentOwnerOther2021-10-26Purchase387,500.0$16.0
Flynn James ETenPercentOwnerOther2021-10-26Purchase387,500.0$16.0
Deerfield Mgmt V, L.P.TenPercentOwnerOther2021-10-26Purchase387,500.0$16.0
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)TenPercentOwnerOther2021-10-26Purchase387,500.0$16.0
Deerfield Mgmt L.P.TenPercentOwnerOther2021-10-26Purchase387,500.0$16.0
DEERFIELD PARTNERS, L.P.TenPercentOwnerOther2021-10-26Purchase387,500.0$16.0
Flynn James ETenPercentOwnerOther2021-10-26Purchase387,500.0$16.0
Deerfield Mgmt V, L.P.TenPercentOwnerOther2021-10-26Purchase387,500.0$16.0
Rock Springs Capital Management LPTenPercentOwner2021-10-26Purchase500,000.0$16.0
Rock Springs Capital Master Fund LPTenPercentOwner2021-10-26Purchase500,000.0$16.0
Rock Springs Capital LLCTenPercentOwner2021-10-26Purchase500,000.0$16.0
Four Pines Master Fund LPTenPercentOwner2021-10-26Purchase500,000.0$16.0
BAY CITY CAPITAL LLCTenPercentOwner2021-10-26Purchase312,500.0$16.0
Atlas Venture Fund XI, L.P.TenPercentOwner2021-10-26Purchase187,500.0$16.0
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2021-10-26Purchase187,500.0$16.0
RiverVest Venture Fund IV, L.P.TenPercentOwner2021-10-26Purchase250,000.0$16.0